You are viewing an archive version of the PSNC website taken on 18th April 2013. This site is not updated, and may be out of date or relate to old NHS structures.
For updated and current information, please visit our new website at www.psnc.org.uk
Skip Navigation
PSNC Home Page
Advanced Search
.

Pharmaceutical Services Negotiating Committee

Drug Tariff News

April 2013 Concessions (UPDATED)

The following products have been announced as NCSO for the month of April:

Indapamide 2.5mg tablets (28) (NEW)

The required endorsement must include the letters ‘NCSO’, manufacturer or supplier or brand name and the pack size of the product, the price paid before discount and ex VAT, the pharmacist’s initials and the date.

 

The following products have been announced as price concessions for the month of April:

  • Hydralazine 50mg tablets (56) - £16.32 (NEW)
  • Isosorbide mononitrate 10mg tablets (56) - £13.10
  • Nabumetone 500mg tablets (56) - £6.18
  • Naftidrofuryl 100mg capsules (84) - £8.10
  • Temazepam 10mg tablets (28) - £24.00
  • Temazepam 20mg tablets (28) - £23.00
  • Trazodone 50mg capsules (84) - £23.92
  • Trazodone 100mg capsules (56) - £28.14
  • Trazodone 150mg tablets (28) - £16.08

Price concessions do not require any additional endorsements as the agreed price is applied automatically by the NHSBSA when they process the prescriptions submitted with the April bundle.

 

The Department of Health set price concessions using information derived from manufacturers and wholesalers.  Where contractors are unable to purchase products at the set prices, they may wish to challenge suppliers for an explanation of why their prices are so high.  Where contractors are unable to secure products at or near the concessionary price, PSNC would like to receive copies of invoices for monitoring of prices.  Please email these to info@psnc.org.uk or fax to 0207 833 8007 for the attention of the Information Team.

PSNC is still in discussion with the Department of Health on a number of generic medicines in short supply. Please note that PSNC is unable to provide details of generic products that are suspected of being affected by generic supply problems unless and until the Department of Health grants a concession.

Contractors will be alerted to any updates through our website and via our e-news email.  If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.

Please ensure you continue to report any problems with supply to PSNC using our feeback form.

Posted 16 April 2013

< Back